Mycobacterium smegmatis (Trevisan) Lehmann and Neumann
商品貨號
B177026
Application
Produces antitumor immunity stimulant
Produces vaccine adjuvant
Preparation of non-specific stimulant for antitumor immunity
Biosafety Level
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
freeze-dried
Disclosure
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC.
Berger FM, et al. Process for preparing vaccine adjuvant. US Patent 4,036,953 dated Jul 19 1977
Adam A, et al. Agents effective as non-specific stimulants for antitumoral immunity derived from micro-organisms of the mycobacteria type and methods for their manufacture. US Patent 3,876,779 dated Apr 8 1975
